Home . Resources
[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more News
A.I
28/04/2022
Places to meet and engage conversation with our experts in AI and Drug Discovery
Come back regularly to check if there is a meeting nearby your place to meet one of our experts in both AI & Drug Discovery.
Corporate
Service
27/04/2022
[Congress] Meet Oncodesign in person this spring
Check out where to meet Oncodesign this spring... surely we can arrange a meeting somewhere.
Biotech
11/04/2022
Parkinson’s Disease: Growing Prevalence And Continued Significant Medical Need
Explore the disease & find out about our strategic R&D collaboration with Servier: info, press releases & video!
Corporate
Financial
07/04/2022
Oncodesign confirms its very good results in 2021 and an attractive outlook for 2022
Read the full press release about our very good results in 2021 & an attractive outlook for 2022 for the group & our BUs Service, Biotech & AI.
Service
28/03/2022
Scientific Posters | AACR 2022
Find all 4 posters that are presented during AACR 2022. They unveil our expertise in oncology using our scientific know-how (medicinal chemistry, radio-imaging, in vivo model and microbiome)
![[CONGRESS] Microbiome & Probiotics](https://www.oncodesign.com/wp-content/uploads/2022/03/Congres-Microbiome-March-2022.jpg)
Service
18/03/2022
[Congress] AACR Annual Meeting | 8-13 April 2022
Meet us in person at the Annual Meeting of the AACR in New Orleans!
Service
16/03/2022
[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Service
14/03/2022
[CONGRESS] Microbiome & Probiotics, 29-30 March 2022
Meet us at the Microbiome & Probiotics congress in San Diego | March 2022. Explore our expertise in assessing the role of microbiome in drug discovery
Service
24/02/2022
Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services
Abzena x Alira Health x Oncodesign: unveil unique integrated solution with specialist services, from biologics discovery to clinical & commercial manufacturing
Biotech
Financial
08/02/2022
SEngine Precision Medicine & Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment
Read all the details of the collaboration agreement for R&D of a new personalized cancer treatment for aggressive and untreatable tumors.
Corporate
Financial
27/01/2022
Oncodesign announces a 2021 turnover of €31.3M, up by 22%, and expects to break even
Find all the 2021 financial information: 2021 turnover of €31.3M, up by 22%, and expects to break even and dive into the BU financial results
Service
14/01/2022
[Congress] Microbiome Movement Drug Development
Oncodesign will be at the digital event Microbiome Movement Drug Development. Take the opportunity to learn more about SOLO Microbiome.